Mo

[Mo @c14aka]

@MHRAgovuk If traditional pathways weren’t designed for advanced personalised therapies, then why has DCVax-L remained under review for nearly 29 months with no public clarity? Glioblastoma patients don’t have time for endless silence. $NWBO #DCVaxL

[Mo @c14aka]

If traditional pathways weren’t designed for advanced personalised therapies, then why has DCVax-L remained under review for nearly 29 months with no public clarity? Glioblastoma patients don’t have time for endless silence. $NWBO #DCVaxL

[MHRAgovuk @MHRAgovuk]

Traditional development pathways weren't designed for many rare diseases.

We're consulting on a new framework that could support earlier access to promising therapies while maintaining patient safety.

Have your say before 30 July 2026
- 🔗 https://t.co/5RkQqWqYmq

[Mo @c14aka]

@sneedweb Shitadel is better

[Mo @c14aka]

29 months. No rejection. No withdrawal. No transparency. Glioblastoma patients are still waiting while DCVax-L remains under MHRA review. At some point silence stops looking cautious and starts looking unacceptable. @MHRAgovuk $NWBO

[Mo @c14aka]

29 months post-MHRA submission. No rejection. No withdrawal. No transparency. Today $NWBO flushed below $0.19 before reclaiming $0.20 into close. The market is frustrated, exhausted and still waiting for answers. At some point this process has to conclude.

[Mo @c14aka]

@ItsMikePoarch Why don't you talk about $nwbo anymore?

[Mo @c14aka]

@ManUtdInPidgin Patrick dorgu

[Mo @c14aka]

@LegacySiu Tevez

[Andrew Caravello, DO @andrewcaravello]

You asked to hear from patients and families. They have been waiting 27+ months on the $NWBO #DCVax MAA. #Glioblastoma is a rare cancer. Median survival is 14 months. A new way forward starts with the application already on your desk.

[MHRAgovuk @MHRAgovuk]

Fewer than 5% of rare diseases have an approved treatment. The average diagnosis takes over five years. We're proposing a new way forward, and we want to hear from patients, families and carers like you.

Open to all, respond before 30th July 2026 – https://t.co/VFRcsEVNoS

[Mo @c14aka]

MHRA now openly discussing modernising regulation for advanced personalised therapies while DCVax-L sits nearly 29 months into review with no rejection or withdrawal. Says a lot about how difficult these next-gen treatments are to regulate. $NWBO

[Mo @c14aka]

$NWBO Interesting new court ruling. Judge rejected Citadel’s argument and confirmed NWBO’s spoofing claims already survived before Professor Mitts’ analyses were added. Not a final win, but definitely another procedural victory for NWBO in the market manipulation case. 👀

[Mo @c14aka]

Legend

[Thomas Owen McCaffrey @ThomasOwenMcCa1]

Hi 👋 Rebecca,

My name is Thomas O.,I was administered the DCVax @UCLA by Dr. Linda Liau in March of 2015. I just donated to your GOFUNDMe. This may sixth I celebrated my 50th birthday. It’s been 11 years since my diagnosis. 11 years to watch my son grow up; he was 3 & a half months old when I had a Gran Mal seizure in my kitchen. I wanted to let you know I feel nurses are the unsung heroes of the hospital. They are the ones keeping you comfortable in times when you can’t communicate. They were many hats & even mind reader in some situations.

I hope my donation helps, but more importantly I hope you read this tweet. Greedy people are against this scientific breakthrough in personalized immunotherapy.
I guess they’re in the U.K as well. Shame on anyone who puts profits over people.
They’ll have there day…

I won’t stop until they do.

Sincerely,
Thomas O.

@LisainNJUSA @kshaughnessy2 @HollensbeAmanda @NHSNW @NorthwestBio @NYMag @ElvirPons @JackAWynn @TheLastWord @LastWeekTonight

[Mo @c14aka]

@TwyfordMar38480 Stole my screenshot 🤣, not your buy mate

[Mo @c14aka]

$NWBO Glioblastoma patients have waited long enough. If the hold-up is manufacturing, data review, or process complexity — fine. But transparency matters. Silence only creates more uncertainty for patients and investors alike. @MHRAgovuk #NWBO #DCVax

[kristen shaughnessy @kshaughnessy2]

$NWBO
Former Firefighter Given Months to Live Turns to DCVax -
With a Song Soaring on the @iTunes Charts to Save Him

@GrampianOnline reports James McPherson, a 46-year-old former firefighter from Moray, Scotland, was diagnosed with glioblastoma in February and given 12-15 months to live.

A charity remix of a local festival song shot to No.3 on the iTunes charts.

All the money is going toward the DCVax - L vaccine which trains the body to attack the cancer cells.

“I know this is going to kill me,” says James. “But with the vaccine I could have another 20 years. I’d settle for that right now.”

Courtesy @yachtmastter

[Mo @c14aka]

$NWBO Thousands of glioblastoma patients have waited years for new treatment options. DCVax-L has generated global attention, yet patients are still waiting for clarity. Transparency and timely decisions matter when lives are involved. @MHRAgovuk #NWBO #DCVax #Glioblastoma

[Mo @c14aka]

@jaygreco194737 What is this?, quick summary

[Mo @c14aka]

@MHRAgovuk Approve DC Vax L